SCHEMBL7879653

SCHEMBL7879653

CNC(N)=NC(=O)c1cc2c(C)ccc(OCCCN(C)C)c2[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
HRH3 Q9Y5N1 2/20 0.35
ADRA2A P08913 1/20 0.35
ADRA1D P25100 1/20 0.35
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
KDM4E B2RXH2 4/20 0.34
HSD17B10 Q99714 1/20 0.34
ATM Q13315 1/20 0.33
LMNA P02545 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDR P35968 2/20 0.33
PDGFRB P09619 1/20 0.33
PDGFRA P16234 1/20 0.33
ESR1 P03372 1/20 0.33
HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7881182 0.99 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2CYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL7879941 0.94 KDM4E (0.38) ALDH1A1SMN1; SMN2CYP1A2CYP2D6HRH3
SCHEMBL7879685 0.90 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP2D6CYP2C19HRH3
SCHEMBL7882192 0.90 KDM4E (0.44) ALDH1A1HRH3THRATHRBKDM4E
Hydrochloric Acid SCHEMBL7884702 0.89 KDM4E (0.37) ALDH1A1CYP1A2CYP2D6CYP2C19HRH3
Hydrochloric Acid SCHEMBL7881522 0.89 KDM4E (0.43) ALDH1A1HRH3THRATHRBKDM4E
SCHEMBL7884308 0.89 KDM4E (0.33) ALDH1A1SMN1; SMN2CYP1A2KDM4EHSD17B10
Hydrochloric Acid SCHEMBL7884769 0.88 KDM4E (0.39) ALDH1A1SMN1; SMN2HRH3ADRA2AADRA1D
Hydrochloric Acid SCHEMBL8633729 0.88 KDM4E (0.39) ALDH1A1SMN1; SMN2HRH3ADRA2AADRA1D
Hydrochloric Acid SCHEMBL7884332 0.88 TOP2A (0.33) ALDH1A1SMN1; SMN2CYP1A2KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed